BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27463501)

  • 1. Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.
    Engelhard M; Brittinger G; Heinz R; Theml H; Bartels H; Binder T; Fülle HH; Gerhartz H; Gunzer U; Ludwig F; Ludwig WD; Nowicki L; Oertel J; Pees HW; Pralle H; Rühl U; Schilling CV; Spann W; Szeimies U; Wetzel HJ; Zwingers T; Feller AC; Stein H; Lennert K
    Leuk Lymphoma; 1991; 5 Suppl 1():161-73. PubMed ID: 27463501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas].
    Brittinger G; Bartels H; Common H; Dühmke E; Engelhard M; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E
    Onkologie; 1986 Apr; 9(2):118-25. PubMed ID: 3520420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoplasmacytic/lymphoplasmacytoid lymphoma: a clinical entity distinct from chronic lymphocytic leukaemia?
    Heinz R; Stacher A; Pralle H; Theml H; Brunswicker F; Burkert M; Common H; Fülle HH; Grisar T; Grüneisen A; Herrmann F; Leopold H; Liffers R; Meusers P; Nowicki L; Nürnberger R; Rengshausen H; Rühl U; Schoengen A; Schmidt M; Wirthmüller R; Schwarze EW; Brittinger G
    Blut; 1981 Sep; 43(3):183-92. PubMed ID: 7343014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma.
    Juliusson G; Robèrt KH; Ost A; Friberg K; Biberfeld P; Nilsson B; Zech L; Gahrton G
    Blood; 1985 Jan; 65(1):134-41. PubMed ID: 3871161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracytoplasmic immunoglobulins in the differential diagnosis of lymphocytic lymphomas of the B-CLL type and immunocytic lymphomas.
    Martinsson U; Glimelius B; Hagberg H; Simonsson B; Sundström C
    Acta Radiol Oncol; 1985; 24(6):527-35. PubMed ID: 3006443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune phenotype and prognosis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma.
    Juliusson G; Ost A; Biberfeld P; Robèrt KH; Gahrton G
    Acta Med Scand; 1985; 218(3):335-40. PubMed ID: 3878068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
    Schmidt D; Radzun HJ; Schwarze EW; Stein H; Parwaresch MR
    Cancer; 1980 Dec; 46(12):2676-81. PubMed ID: 6969627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface immunoglobulin density in the differential diagnosis of B-cell chronic lymphocytic leukemia and leukemic immunocytoma.
    Ludescher C; Gattringer C; Weger AR; Drach J; Thaler J; Bitschmann R; Huber H
    Leuk Res; 1992; 16(2):191-6. PubMed ID: 1372055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology and Immunocytochemistry of Lymph Node Biopsies in Chronic Lymphocytic Leukemia and Immunocytoma.
    Lennert K; Tamm I; Wacker HH
    Leuk Lymphoma; 1991; 5 Suppl 1():157-60. PubMed ID: 27463500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
    Molica S; Brugiatelli M; Callea V; Morabito F; Levato D; Nobile F; Alberti A
    Eur J Haematol; 1994 Apr; 52(4):216-21. PubMed ID: 8005231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
    Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.